-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Vitro Biopharma, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2012 to 2024.
- Vitro Biopharma, Inc. Amortization of Intangible Assets for the quarter ending January 31, 2025 was $7.62K, a 55% decline year-over-year.
- Vitro Biopharma, Inc. Amortization of Intangible Assets for the twelve months ending January 31, 2025 was $54.4K, a 53% decline year-over-year.
- Vitro Biopharma, Inc. annual Amortization of Intangible Assets for 2024 was $63.7K, a 51.6% decline from 2023.
- Vitro Biopharma, Inc. annual Amortization of Intangible Assets for 2023 was $132K, a 0% increase from 2022.
- Vitro Biopharma, Inc. annual Amortization of Intangible Assets for 2022 was $132K.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)